Stock Rating Upgrade
The Value Trend Rating for Vanda Pharmaceuticals Inc (NASDAQ: VNDA) improved in recent days from D to C reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in our next report.
Recent Price Action
Vanda Pharmaceuticals Inc (NASDAQ: VNDA) stock closed at $4.62 on 4/26/24 after a large increase of 3.1%. However, trading volume in this advance was exceptionally low at 31% of normal. The stock has declined -7.0% during the last week and has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
VNDA’s future returns on capital are forecasted to be in line with the cost of capital. Accordingly, the company is expected to be Value Creation neutral.
Vanda Pharmaceuticals has a current Value Trend Rating of C (Low Neutral). This VT Rating improved in recent days from D previously. With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Vanda Pharmaceuticals has a good Appreciation Score of 71 but a poor Power Rating of 23, with the Low Neutral Value Trend Rating the result.
Be the first to comment